The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis.
 
Dmytro Trukhin
No Relationships to Disclose
 
Elena Poddubskaya
No Relationships to Disclose
 
Andric Zoran
No Relationships to Disclose
 
Igor Bondarenko
No Relationships to Disclose
 
Serhii Shevnia
No Relationships to Disclose
 
Bojan Zaric
Consulting or Advisory Role - Aileron Therapeutics; AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; MSD Oncology; Roche/Genentech; Yuhan
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; MSD Oncology; Roche/Genentech; Takeda
Expert Testimony - AstraZeneca; MSD Oncology; Takeda
 
Ravishankar Bellala
No Relationships to Disclose
 
Chaiyut Charoentum
Research Funding - AstraZeneca; Novartis; Roche/Genentech
 
Luis Perez
Employment - Mabxience
Research Funding - Mabxience (Inst)
 
Felicitas Bullo
Employment - Mabxience
Research Funding - Mabxience (Inst)
 
Fernanda Garcia
Employment - Mabxience
Research Funding - Mabxience (Inst)